跳至主要内容
临床试验/JPRN-UMIN000020324
JPRN-UMIN000020324招募中4 期

Relationship between contrast sensitivity, vision-related quality of life and foveal microstructure in patients with diabetic macular edema following aflibercept therapy. - Relationship between contrast sensitivity, vision-related quality of life and foveal microstructure in patients with diabetic macular edema following aflibercept therapy.

niversity of Tsukuba0 个研究点目标入组 20 人开始时间: 2016年3月8日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)The study eye is better than fellow eye (2)History of vitreoretinal surgery (3)Laser photocoagulation in the study eye within 90 days before Day 1 (4)More than 1 treatment with Direct laser/grid laser (5)Previous use of intraocular or periocular corticosteroids in the study eye within 120 days (6)Previous treatment with anti-angiogenic drugs in either eye within 90 days (7)Proliferative diabetic retinopathyin the study eye, (8)History of idiopathic or autoimmune uveitis (9)Any intraocular surgerywithin 90 days before Day 1 (10)Aphakia (11)Vitreomacular traction (12)Current iris neovascularization, vitreoushemorrhage, or tractional retinal detachment (13)Pre-retinal fibrosis (14)Structural damage to the center of the macula (15)History of endophthalmitis (16)Infectious blepharitis, keratitis,scleritis or conjunctivitis (17)Uncontrolled graucoma (18)High intraocular pressure in the study ey (19)High myopia (20)History of disease that can result in decreased visual acuity (21)Only one functional eye (22)Ocular media insufficient to obtain fundus and OCT images in the study eye (23)Serious systemic infection (24)Administration of systemic anti-angiogenic agents within 180 days before day 1 (25)Uncontrolled blood pressure (26)Uncontrolled diabetes mellitus (27)History of cerebrovascular accident and/or Myocardial infarction within 180 days before day 1 (28)Renal failure (29)Systemic disease patients who need treatment that may affect outcomes (30)Pregnant or breast-feeding women (31)Female subjects wish for a pregnancy within the intended treatment period (32)Allergy to fluorescein (33)Hypersensitive to aflibercept (34)Previous participation in any studies of investigational drugs within 30 days preceding Day 1 (35)Subjects who judged by a investigator to be inappropriate for the study

研究者

发起方
niversity of Tsukuba

相似试验

Relationship between contrast sensitivity,... | 临床试验